The objective of this study is to obtain female first-catch urine, vaginal swab, endocervical swab, and cervical specimens collected in PreservCyt Solution ("PreservCyt Specimens") for testing with the APTIMA Trichomonas vaginalis (ATV) Assay. These specimens will be used to demonstrate assay performance on the PANTHER System is comparable to performance on the TIGRIS System.
Study Type
OBSERVATIONAL
Enrollment
532
APTIMA Trichomonas vaginalis (ATV) Assay
University of Alabama, Birmingham
Birmingham, Alabama, United States
Wishard Hospital - Indiana University School of Medicine
Indianapolis, Indiana, United States
Louisiana State University
New Orleans, Louisiana, United States
New England Center for Clinical Research
Fall River, Massachusetts, United States
Positive Percent Agreement Using the TIGRIS Instrument as a Reference.
Positive Percent Agreement Using the TIGRIS Instrument as a Reference.
Time frame: approximately one year
Negative Percent Agreement Using the TIGRIS Instrument as a Reference.
Negative Percent Agreement Using the TIGRIS Instrument as a Reference.
Time frame: approximately one year
Positivity Rate
Positivity Rate
Time frame: approximately one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Geneuity Clinical Research Services
Maryville, Tennessee, United States
Planned Parenthood Gulf Coast
Houston, Texas, United States